Joel Lewis insider trades

Open-market stock purchases and sales by Joel Lewis, President and CEO at Galectin Therapeutics Inc, from SEC Form 4 filings since Dec 14, 2017.

Track record: 25% of 4 scored buys are up 5% or more since purchase, averaging +4%.

Recent trades

DateStockTradeValue
Jan 16, 2026GALT Galectin Therapeutics IncBought (not open market)—
Jan 16, 2026GALT Galectin Therapeutics IncBought (not open market)—
Jan 16, 2026GALT Galectin Therapeutics IncBought (not open market)—
Jan 6, 2026GALT Galectin Therapeutics IncSold$135K
Jan 5, 2026GALT Galectin Therapeutics IncSold (not open market)$219K
Jan 5, 2026GALT Galectin Therapeutics IncSold$108K
Jan 5, 2026GALT Galectin Therapeutics IncSold (not open market)$219K
Jan 2, 2026GALT Galectin Therapeutics IncBought (not open market)—
Jan 2, 2026GALT Galectin Therapeutics IncSold$77.9K
Dec 17, 2025GALT Galectin Therapeutics IncSold$55.2K
Dec 17, 2025GALT Galectin Therapeutics IncBought (not open market)—
Nov 18, 2025GALT Galectin Therapeutics IncSold$41.7K
Nov 18, 2025GALT Galectin Therapeutics IncBought (not open market)—
Nov 17, 2025GALT Galectin Therapeutics IncSold$94.6K
Nov 17, 2025GALT Galectin Therapeutics IncBought (not open market)—
Nov 10, 2025GALT Galectin Therapeutics IncBought (not open market)$4.5K
Nov 10, 2025GALT Galectin Therapeutics IncSold$11.3K
Nov 5, 2025GALT Galectin Therapeutics IncBought (not open market)—
Nov 5, 2025GALT Galectin Therapeutics IncSold$1.2K
Nov 5, 2025GALT Galectin Therapeutics IncBought (not open market)—
Nov 4, 2025GALT Galectin Therapeutics IncSold$87.5K
Nov 4, 2025GALT Galectin Therapeutics IncBought (not open market)—
Nov 3, 2025GALT Galectin Therapeutics IncSold$7.8K
Nov 3, 2025GALT Galectin Therapeutics IncBought (not open market)—

Companies traded

  • GALT Galectin Therapeutics Inc: 6 buys, 12 sales, last Jan 16, 2026

Get free alerts when Joel Lewis files a new trade →